SCHEMBL7724858

SCHEMBL7724858

C#CCOC(=O)CNC(=O)C(=O)[C@H](CCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(C)C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.40
▸ CALCRL Q16602 5/20 0.40
▸ CMA1 P23946 5/20 0.39
▸ CASP3 P42574 3/20 0.39
▸ CASP2 P42575 3/20 0.39
▸ ELANE P08246 3/20 0.37
▸ EPHA2 P29317 1/20 0.37
▸ KEAP1 Q14145 1/20 0.36
▸ PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7736665 0.93 MALT1 (0.41) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7736326 0.93 CMA1 (0.41) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7724818 0.91 CASP3 (0.40) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7728258 0.90 CALCRL (0.38) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7736078 0.90 CMA1 (0.46) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7736050 0.90 CASP3 (0.41) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7736353 0.90 CASP3 (0.41) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7736683 0.90 CASP3 (0.41) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7724771 0.90 CASP3 (0.40) MALT1CALCRLCMA1CASP3CASP2
SCHEMBL7724238 0.90 CASP3 (0.40) MALT1CALCRLCMA1CASP3CASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800434-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION 2004-10-05 — — US disclosed
US-6800434-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION 2004-10-05 — — US disclosed
Send feedback